|

Dose Level 1A: 2 x 10^7 cells/m2 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Baylor College of Medicine1

Indications

  • EBV Related Non-Hodgkin's Lymphoma1
  • EBV-Related Lymphoproliferative Disorder1
  • EBV-Related Hodgkin Lymphoma1
  • Cancer1

Houston, Texas1 trial

EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma

Houston Methodist Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.